The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines

Eur Respir J. 2019 Oct 10;54(4):1901272. doi: 10.1183/13993003.01272-2019. Print 2019 Oct.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Drug Therapy, Combination / methods
  • Duration of Therapy*
  • Humans
  • Practice Guidelines as Topic
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • World Health Organization

Substances

  • Antitubercular Agents